Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response

Trends in Immunology

Volumn 24, Issue 6, 2003, Pages 326-333

  Muller, William A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CD31 ANTIGEN; CD99 ANTIGEN; CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE B; JUNCTIONAL ADHESION MOLECULE C; UNCLASSIFIED DRUG;

CELL ADHESION; CELL COMMUNICATION; CELL INTERACTION; CELL JUNCTION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; LEUKOCYTE MOTILITY; MONOCYTE; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; ANIMAL; CYTOLOGY; IMMUNOLOGY; LEUKOCYTE; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PHYSIOLOGY; TIGHT JUNCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LEUKOCYTES; TIGHT JUNCTIONS;

EID: 0038180539     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00117-0     Document Type: Review

References (82)

1. Fox A., Harrison L.C. Innate immunity and graft rejection. Immunol. Rev. 173:2000;141-147.
2. Hoffmann J., et al. Phylogenetic perspectives in innate immunity. Science. 284:1999;1313-1318.
3. Schenkel A.R., et al. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3:2002;143-150.
4. Feng D., et al. Neutrophils emigrate from venules by a transendothelial cell pathway in response to fMLP. J. Exp. Med. 187:1998;903-915.
5. Muller W.A. Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation. 8:2001;181-193.
6. Dejana E., et al. Endothelial cell-to-cell junctions. FASEB J. 9:1995;910-918.
7. Huang A.J., et al. Effects of human neutrophil chemotaxis across human endothelial cell monolayers on the permeability of these monolayers to ions and macromolecules. J. Cell. Physiol. 135:1988;355-366.
8. Huang A.J., et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J. Cell Biol. 120:1993;1371-1380.
9. Del Maschio A., et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J. Cell Biol. 135:1996;497-510.
10. Moll T.E., et al. In vitro degradation of endothelial catenins by a neutrophil protease. J. Cell Biol. 140:1998;1.
11. Allport J.R., et al. Endothelial-dependent mechanisms regulate leukocyte transmigration: A process involving the proteasome and disruption of the vascular endothelial-cadherin complex and endothelial cell-to-cell junctions. J. Exp. Med. 186:1997;517-527.
12. Burns A.R., et al. Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J. Immunol. 159:1997;2893-2903.
13. Burns A.R., et al. Analysis of tight junctions during neutrophil transendothelial migration. J. Cell Sci. 113:2000;45-57.
14. Burns A.R., et al. Relationship between tight junctions and leukocyte transmigration. Cereijido M., Anderson J. Tight Junctions. 2001;629-652 CRC Press.
15. Shaw S.K., et al. Real-time imaging of vascular endothelial-cadherin during transmigration across endothelium. J. Immunol. 167:2001;2323-2330.
16. Allport J.R., et al. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J. Cell Biol. 148:2000;203-216.
17. Gelin C., et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J. 8:1989;3253-3259.
18. Cunningham S.A., et al. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J. Biol. Chem. 275:2000;34750-34756.
19. Aurrand-Lions M., et al. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 98:2001;3699-3707.
20. Muller W.A., et al. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J. Exp. Med. 170:1989;399-414.
21. Newman P.J., et al. PECAM-1 [CD31] cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 247:1990;1219-1222.
22. Muller W.A., et al. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:1993;449-460.
23. Liao F., et al. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182:1995;1337-1343.
24. Bogen S., et al. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179:1994;1059-1064.
25. Liao F., et al. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J. Exp. Med. 185:1997;1349-1357.
26. Vaporciyan A.A., et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science. 262:1993;1580-1582.
27. Christofidou-Solomidou M., et al. Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J. Immunol. 158:1997;4872-4878.
28. Liao F., et al. Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J. Immunol. 163:1999;5640-5648.
29. Gumina R.J., et al. Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation. 94:1996;3327-3333.
30. Murohara T., et al. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol. 156:1996;3550-3557.
31. Qing Z., et al. Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J. Neuropathol. Exp. Neurol. 60:2001;798-807.
32. Duncan G.S., et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162:1999;3022-3030.
33. Dangerfield J., et al. PECAM-1 (CD31) homophilic interaction up-regulates α6β1 on transmigrated neutrophils in vivo and plays a functional role in the ability of α6 integrins to mediate leukocyte migration through the perivascular basement membrane. J. Exp. Med. 196:2002;1201-1211.
34. Wakelin M.W., et al. An anti-platelet/endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through basement membrane. J. Exp. Med. 184:1996;229-239.
35. Aubrit F., et al. The biochemical characterization of E2, a T cell surface molecule involved in rosettes. Eur. J. Immunol. 19:1989;1431-1436.
36. + thymocytes. J. Immunol. 154:1995;26-32.
37. Bernard A. CD99 workshop panel report. Kishimoto T. Proceedings of the VIth International Leukocyte Differentiation Antigen Workshop, Kobe, Japan, 1996. Proceedings of the VIth International Leukocyte Differentiation Antigen Workshop, Kobe, Japan, 1996. 1997;75-77 Garland Publishers.
38. Bernard G., et al. Apoptosis of immature thymocytes mediated by E2/CD99. J. Immunol. 158:1997;2543-2550.
39. Hahn J.-H., et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J. Immunol. 159:1997;2250-2258.
40. Choi E.Y., et al. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes. J. Immunol. 161:1998;749-754.
41. Waclaveicek M., et al. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J. Immunol. 161:1998;4671-4678.
42. Wingett D., et al. A role for CD99 in T cell activation. Cell. Immunol. 193:1999;17-23.
43. 1-dependent T cell adhesion of inflamed vascular endothelium under flow conditions. Eur. J. Immunol. 30:2000;3061-3065.
44. Lampugnani M.G., et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell Biol. 118:1992;1511-1522.
45. Ali J., et al. Vascular endothelial cadherin (VE-Cadherin): cloning and role in endothelial cell-cell adhesion. Microcirculation. 4:1997;267-277.
46. Navarro P., et al. Catenin-dependent and independent functions of vascular endothelial cadherin. J. Biol. Chem. 270:1995;30965-30972.
47. Breviario F., et al. Functional properties of human vascular endothelial cell cadherin (7b4/cadherin-5), an endothelium-specific cadherin. Arterioscler. Thromb. Vasc. Biol. 15:1995;1229-1239.
48. Gotsch U., et al. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J. Cell Sci. 110:1997;583-588.
49. Martin-Padura I., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142:1998;117-127.
50. Williams L.A., et al. Identification and characterization of human junctional adhesion molecule (JAM). Mol. Immunol. 36:1999;1175-1188.
51. Liu Y., et al. Human junctional adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113:2000;2363-2374.
52. Sobocka M.B., et al. Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood. 95:2000;2600-2609.
53. Del Maschio A., et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 190:1999;1351-1356.
54. Lechner F., et al. Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocye influx into the meninges after viral or bacterial infection. J. Infect. Dis. 182:2000;978-982.
55. 2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3:2002;151-158.
56. Ozaki H., et al. Cutting edge: combined treatment of TNF-α and IFN-γ causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 163:1999;553-557.
57. Palmeri D., et al. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J. Biol. Chem. 275:2000;19139-19145.
58. Arrate M.P., et al. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J. Biol. Chem. 276:2001;45826-45832.
59. Liang T.W., et al. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J. Immunol. 168:2002;1618-1626.
60. Cunningham S.A., et al. JAM2 interacts with α4β1. Facilitation by JAM3. J. Biol. Chem. 277:2002;27589-27592.
61. Johnson-Leger C., et al. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood. 100:2002;2479-2486.
62. Santoso S., et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196:2002;679-691.
63. i signaling during transmigration of polymorphonuclear leukocytes. Blood. 96:2000;3816-3822.
64. Hixenbaugh E.A., et al. Chemoattractant-stimulated neutrophils induce regulatory myosin light chain phosphorylation and isometric tension development in endothelial cells. Am. J. Physiol. 273:1997;H981-H988.
65. Saito H., et al. Endothelial myosin light chain kinase regulates neutrophil migration across human umbilical vein endothelial cell monolayer. J. Immunol. 161:1998;1533-1540.
66. 2 integrins triggers neutrophil-dependent alteration in endothelial barrier function. J. Exp. Med. 191:2000;1829-1839.
67. Gautam N., et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat. Med. 7:2001;1123-1127.
68. Lorenzon P., et al. Endothelial cell E-and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J. Cell Biol. 142:1998;1381-1391.
69. Mamdouh Z., et al. Targeted recycling of PECAM from endothelial cell surface-connected compartments during diapedesis. Nature. 421:2003;748-753.
70. Muller W.A. Transendothelial migration of leukocytes. Peltz G. Leukocyte Recruitment in Inflammatory Disease. 1996;3-18 R.G. Landis Company.
71. Muller W.A. Leukocyte-endothelial cell adhesion molecules in transendothelial migration. Gallin J.I., Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 1999;585-592 Lippincott Williams & Wilkins.
72. Muller W.A., Weigl S. Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay. J. Exp. Med. 176:1992;819-828.
73. Cooper D., et al. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc. Natl. Acad. Sci. U. S. A. 92:1995;3978-3982.
74. Parkos C., et al. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J. Cell Biol. 132:1996;437-450.
75. Hawkins H.K., et al. Leukocyte adhesion deficiency: clinical and postmortem observations. Pediatr. Pathol. 12:1992;119-130.
76. Mizgerd J.P., et al. Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J. Exp. Med. 186:1997;1357-1364.
77. Doerschuk C.M., et al. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microciruclation of rabbits. J. Immunol. 144:1990;2327-2333.
78. Bird I.N., et al. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology. 80:1993;553-560.
79. Miller M., et al. Eosinophil tissue recruitment to sites of allergic inflammation in the lung is platelet endothelial cell adhesion molecule independent. J. Immunol. 167:2001;2292-2297.
80. Thompson R.D., et al. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood. 97:2001;1854-1860.
81. Aurrand-Lions M., et al. Cloning of JAM-2 and JAM-3: an emerging junctional adhesion molecular family? Curr. Top. Microbiol. Immunol. 251:2000;91-98.
82. Aurrand-Lions M., et al. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J. Biol. Chem. 276:2001;2733-2741.